— Know what they know.
Not Investment Advice

ELIXF OTC

Elixxer Ltd.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +199.1% 1Y: -55.4% 3Y: -97.0% 5Y: -100.0%
$0.03
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 49 · $3.2M mcap · 15M float · 0.0073% daily turnover · Short 54% of daily vol

Balance Sheet Trends

Total Assets
$2M -24.0% ▼
5Y CAGR: -34.0%
Total Liabilities
$15M +22.7% ▲
5Y CAGR: +29.0%
Shareholders Equity
-$13M -36.4% ▼
Cash & Investments
$20K +0.0% ▲
5Y CAGR: -36.6%
Total Debt
$12M +23.4% ▲
5Y CAGR: +30.1%
Net Debt
$12M +23.4% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2024
— Assets —
Cash$1M$177K$39K$20K$20K
Short-Term Investments$0$8M$1M$0$0
Cash & ST Investments$1M$8M$1M$20K$20K
Net Receivables$0$0$45K$11K$50K
Inventory$0$0$0$0$0
Other Current Assets$0$0$0$0$0
Total Current Assets$1M$8M$2M$31K$71K
Property, Plant & Equip.$3K$0$0$0$0
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$11M$2M$580K$751K$825K
Other Non-Current Assets-$0$0$1M$2M$1M
Total Non-Current Assets$11M$2M$2M$2M$2M
Total Assets$12M$10M$3M$3M$2M
— Liabilities —
Accounts Payable$1M$1M$2M$0$2M
Short-Term Debt$8M$4M$3M$10M$12M
Deferred Revenue$1$0$1$0$0
Other Current Liabilities$477K$9K$60K$3M$1M
Total Current Liabilities$9M$5M$4M$12M$15M
Long-Term Debt$0$0$2M$0$0
Other Non-Current Liab.$0$0$0$0$0
Total Non-Current Liabilities$0$0$2M$0$0
Total Liabilities$9M$5M$9M$12M$15M
— Equity —
Common Stock$29M$31M$32M$53M$53M
Retained Earnings-$36M-$39M-$66M-$85M-$88M
Accumulated OCI$2M$3M$53K$58K$32K
Total Stockholders Equity$3M$5M-$5M-$10M-$13M
Total Liabilities & Equity$12M$10M$3M$3M$2M
— Key Metrics —
Total Debt$8M$4M$7M$10M$12M
Net Debt$6M$4M$7M$10M$12M
Total Investments$11M$10M$3M$751K$825K

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms